Dr. Seung Koo Lee’s principal research concentrates on the development of, (1) innovative multi-functional molecular imaging probes for various disease states including cancers and, (2) drug delivery systems for diagnostic, therapeutic and clinical applications. The primary focus of the aforementioned research is in two specific areas: 1) the use of nanoprobes in cell tracking and molecular imaging and, 2) the use of therapeutic nanoparticle applications in the targeted delivery of various biological ingredients (e.g., small interfering RNA (siRNA), microRNA (miRNA), peptide drugs) for oncological treatments.
Associated Lab Members
Dr. Seung Koo Lee is an assistant professor of cell biology research in Radiology Department at the Weill Cornell Medicine. He earned his Ph.D. in immunology from Seoul National University, Seoul, Korea. During his Ph.D. course, he studied the signaling mechanisms of vitamin C that control tumor proliferation, and apoptosis in colon cancer and melanoma. He then completed postdoctoral training at the Houston Methodist Research Institute, where he invented a layer-by-layer nanoplatform (LbLN) that delivers a short interfering RNA (siRNA) and imaging probe to various cancers. His research focuses on the development of, (1) innovative multi-functional molecular imaging probes for various disease states including cancers and, (2) drug delivery systems for diagnostic, therapeutic and clinical applications.
More than a decade ago, to improve cell tracking efficiency, Dr. Seung Koo Lee, in the lab of Dr. Ching Tung, formulated a layer-by-layer nanoplatform. ...
Using layer-by-layer nanoplatform (LbLN) technology, Seung Koo Lee invented a state-of-the-art cell fate tracker (DL2) that showed the...
